Product category:
Clinical chemistry analysis
News Release from: Quotient Diagnostics | Subject: Quo-Test
Edited by the Laboratorytalk Editorial
Team on 16 November 2006
Quenching the thirst for rapid diabetes
testing
Quotient Diagnostics has launched the Quo-Test point-of-care system which it says heralds a new era in diabetes testing, using fluorescent quenching technology to give A1C results in three minutes
By combining the simultaneous measurement of the test's absorption and fluorescence quenching, Quo-Test delivers in one simple step, A1C results from blood in under three minutes Compact, robust and easy-to-use, Quo-Test enables clinics and doctors' offices to perform laboratory quality testing with full confidence during a single patient visit
This article was originally published on Laboratorytalk on 4 Jul 2008 at 8.00am (UK)
Related stories
Strong demand for automated peptide synthesisers
Activotec has reported strong demand for its Activo-P11 peptide synthesiser, an easy to use instrument for synthesis of very high quality peptides
Trial kit for 2D Dige experiments
GE Healthcare introduces a protein labelling trial kit for 2D fluorescence difference gel electrophoresis (2D Dige), offering a quick, easy and low-cost opportunity for scientists new to the system
Diabetes is one of the most challenging health problems in the 21st century, with close to 200 million people worldwide already diagnosed as having diabetes.
In addition there is strong reason to believe that over half the diabetics in the world still remain undiagnosed.
According to Quotient's CEO David Chatterton the trend is for both diagnosis and follow-up to be performed in special clinics, hence the development of Quo-Test.
"We have drawn on our broad experience in both assay and instrument development to create an instrument that we are confident will have a major impact on diabetes care".
Quo-Test exploits the so-called fluorescent quenching properties of a patented reagent to measure A1C in a way that matches the performance of existing laboratory-based methods.
First, the fluorescence of a conjugate of boronic acid and a fluorophore is reduced (or quenched) upon binding to cis-diol groups that are present on carbohydrates which are attached to haemoglobin molecules.
By using solid state opto-electronic technology the Quo-Test desktop reader quantifies the concentration of A1C in the sample from this subtle quenching effect.
Secondly the total amount of haemoglobin is quantified by absorption measurement.
The combination of these two measures produces an A1C % result.
Quo-Test is a fully automated homogenous assay system, ie, there are no separation steps and the system controls all the critical steps that may influence or affect the quality of the result.
All of this combines to deliver results in about three minutes from a blood sample of under 5ul.
Quo-Test is being launched as a starter kit containing a reader, barcode scanner, mini-printer and a pack of ten disposable cartridges.
• Quotient Diagnostics: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
